Neuland Lab begins commercial production at expanded Unit 1 and Unit 3

Business Updates View source PDF Explain this filing

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.1%Reaction day

₹19050.00

prior close

₹19149.00

announcement price

After-mkt

timing

Nifty Smallcap 250market+1.4%+1.8% vs market

Pharmaceuticals peers, median of 163sector+0.9%+2.2% vs sector

On the reaction day the stock moved 1.8 pts more than Nifty Smallcap 250 and 2.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

+0.3

15m

-0.1

30m

-0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.1+1.4+1.8+0.9+2.2

Next day

+1.0+1.5-0.6+0.7+0.3

+5.1+2.2+2.9+0.2+4.9

+13.4+2.4+10.9+0.7+12.7

+20.3+2.4+17.9+1.4+18.9

+16.8+2.4+14.4+1.1+15.7

+18.1+2.3+15.8+1.5+16.6

15d

+20.3+2.5+17.7+0.8+19.4

+20.2+2.9+17.3+1.6+18.6

+14.9-1.5+16.4+1.5+13.4

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 163Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Neuland Laboratories has commenced commercial production at its expanded capacities at Unit 1 (Bonthapally, Telangana) and Unit 3 (Gaddapotharam, Telangana). This follows earlier communications dated August 1, 2024 and January 21, 2025. The filing is made under SEBI Listing Regulations to keep the stock exchanges informed about the progress of its expansion plans.

Likely market impact

Capacity ramp-up can support higher future revenue and earnings once output is utilized, though near-term costs may weigh.